SYROS PHARMACEUTICALS, INC. Marketable Securities (Non-Current)
SYROS PHARMACEUTICALS, INC. had Marketable Securities (Non-Current) of $2.64 million as of 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:MarketableSecuritiesNoncurrent · last filed 2023-03-02
- 2022-03-31: Marketable Securities, Noncurrent $2.64M.
- 2021-12-31: Marketable Securities, Noncurrent $13.04M.
- 2021-09-30: Marketable Securities, Noncurrent $21.12M.
- 2021-06-30: Marketable Securities, Noncurrent $13.26M.
| Period end | Marketable Securities, Noncurrent |
|---|---|
| 2022-03-31 | $2.64M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $13.04M 10-K · filed 2023-03-02 |
| 2021-09-30 | $21.12M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $13.26M 10-Q · filed 2021-08-05 |